These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys. Eberling JL; Pivirotto P; Bringas J; Bankiewicz KS Exp Neurol; 2000 Oct; 165(2):342-6. PubMed ID: 10993693 [TBL] [Abstract][Full Text] [Related]
24. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates. Wichmann T; Kliem MA; DeLong MR Exp Neurol; 2001 Feb; 167(2):410-24. PubMed ID: 11161630 [TBL] [Abstract][Full Text] [Related]
25. MPTP-Induced hemiparkinsonism in nonhuman primates 6-8 years after a single unilateral intracarotid dose. Emborg-Knott ME; Domino EF Exp Neurol; 1998 Aug; 152(2):214-20. PubMed ID: 9710520 [TBL] [Abstract][Full Text] [Related]
26. Deficits in reaction times and movement times as correlates of hypokinesia in monkeys with MPTP-induced striatal dopamine depletion. Schultz W; Studer A; Romo R; Sundström E; Jonsson G; Scarnati E J Neurophysiol; 1989 Mar; 61(3):651-68. PubMed ID: 2785168 [TBL] [Abstract][Full Text] [Related]
28. Effects of pramipexole on contraversive rotation and functional motor impairments in 1-methyl-4-phenyl1,2,3, 6-tetrahydropyridine-induced chronic hemiparkinsonian monkeys. Domino EF; Ni L; Zhang H; Kohno Y; Sasa M J Pharmacol Exp Ther; 1998 Dec; 287(3):983-7. PubMed ID: 9864283 [TBL] [Abstract][Full Text] [Related]
29. [The effect of amiridin on the MPTP-induced Parkinson-like syndrome in monkeys]. Burov IuV; Metkalova SE; Kustov AE; Petrov GV; Shul'govskiĭ VV Biull Eksp Biol Med; 1992 Nov; 114(11):495-7, 494. PubMed ID: 1290822 [TBL] [Abstract][Full Text] [Related]
30. Asymptomatic striatal dopamine depletion: PET scans in unilateral MPTP monkeys. Guttman M; Yong VW; Kim SU; Calne DB; Martin WR; Adam MJ; Ruth TJ Synapse; 1988; 2(5):469-73. PubMed ID: 3263709 [TBL] [Abstract][Full Text] [Related]
31. [Operant behavioral disorders in monkeys with an MPTP-induced Parkinson-like syndrome]. Burov IuV; Shul'govskiĭ VV; Petrov GV; Tereshchenko LV; Iudin AV Fiziol Zh Im I M Sechenova; 1995 Oct; 81(10):113-6. PubMed ID: 9026250 [No Abstract] [Full Text] [Related]
32. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE Brain; 1990 Jun; 113 ( Pt 3)():617-37. PubMed ID: 2364263 [TBL] [Abstract][Full Text] [Related]
34. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. Taylor JR; Roth RH; Sladek JR; Redmond DE Behav Neurosci; 1990 Aug; 104(4):564-76. PubMed ID: 2206426 [TBL] [Abstract][Full Text] [Related]
35. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys. Slovin H; Abeles M; Vaadia E; Haalman I; Prut Y; Bergman H J Neurophysiol; 1999 Feb; 81(2):858-74. PubMed ID: 10036286 [TBL] [Abstract][Full Text] [Related]
36. [A model of Parkinson's disease: effect of L-dopa therapy on movement parameters and electromyographic activity in monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)]. Doudet D; Gross C; Lebrun-Grandié P; Bioulac B C R Seances Soc Biol Fil; 1985; 179(1):85-97. PubMed ID: 3161601 [TBL] [Abstract][Full Text] [Related]
37. Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism. Kurlan R; Kim MH; Gash DM Mov Disord; 1991; 6(2):111-8. PubMed ID: 2057003 [TBL] [Abstract][Full Text] [Related]
38. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Schneider JS; Pope-Coleman A Neurodegeneration; 1995 Sep; 4(3):245-55. PubMed ID: 8581557 [TBL] [Abstract][Full Text] [Related]